BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2554371)

  • 1. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate.
    Perez CA; Garcia D; Simpson JR; Zivnuska F; Lockett MA
    Radiother Oncol; 1989 Sep; 16(1):1-21. PubMed ID: 2554371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
    Perez CA; Michalski J; Brown KC; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology.
    Perez CA; Pilepich MV; Garcia D; Simpson JR; Zivnuska F; Hederman MA
    NCI Monogr; 1988; (7):85-94. PubMed ID: 3173506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
    Perez CA; Lee HK; Georgiou A; Logsdon MD; Lai PP; Lockett MA
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):581-91. PubMed ID: 8330986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor control in definitive irradiation of localized carcinoma of the prostate.
    Perez AA; Pilepich MV; Zivnuska F
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):523-31. PubMed ID: 3700162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive external irradiation in stages A (T1) and B (T2) carcinoma of the prostate.
    Perez CA; Kirchmann E; Lockett MA
    Am J Clin Oncol; 1993 Oct; 16(5):377-88. PubMed ID: 8213619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pelvic recurrence and distant metastasis in prostate carcinoma following definitive radiotherapy.
    Lai PP; Perez CA; Lockett MA
    Int J Radiat Oncol Biol Phys; 1992; 24(3):423-30. PubMed ID: 1399726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
    Zagars GK; von Eschenbach AC; Ayala AG
    Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy.
    Zagars GK; Ayala AG; von Eschenbach AC; Pollack A
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):237-45. PubMed ID: 7836075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.
    Zelefsky MJ; Whitmore WF; Leibel SA; Wallner KE; Fuks Z
    J Urol; 1993 Dec; 150(6):1860-4. PubMed ID: 8230519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential benefit of improved local tumor control in patients with prostate carcinoma.
    Kuban DA; el-Mahdi AM; Schellhammer PF
    Cancer; 1995 May; 75(9):2373-82. PubMed ID: 7536125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.
    Zelefsky MJ; Whitmore WF
    J Urol; 1997 Jul; 158(1):23-9; discussion 29-30. PubMed ID: 9186315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy in prostate cancer: whole pelvis with prostate boost or small field to prostate?
    Ploysongsang SS; Aron BS; Shehata WM
    Urology; 1992 Jul; 40(1):18-26. PubMed ID: 1621308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
    Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up.
    Amdur RJ; Parsons JT; Fitzgerald LT; Million RR
    Radiother Oncol; 1990 Jul; 18(3):235-46. PubMed ID: 2120741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of combined radiation therapy and hormonal therapy in the management of stage D1 prostate cancer.
    Robnett TJ; Whittington R; Malkowicz SB; Brereton HD; Van Arsdalen K; Drach G; Wein AJ
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1146-51. PubMed ID: 12128114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy of localized prostatic carcinoma].
    Gez E; Netzer-Horowitz Y; Waiman E; Rubinov R; Cohen Y; Kuten A
    Harefuah; 1997 Dec; 133(12):593-6, 664. PubMed ID: 9451865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of whole pelvis versus small-field radiation therapy for carcinoma of prostate.
    Ploysongsang S; Aron BS; Shehata WM; Jazy FK; Scott RM; Ho PY; Morand TM
    Urology; 1986 Jan; 27(1):10-6. PubMed ID: 3079933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
    Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M
    Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.